IRIS
ROSSI, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.297
AS - Asia 3.786
EU - Europa 3.135
SA - Sud America 548
AF - Africa 161
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 12.937
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.167
CN - Cina 1.772
SG - Singapore 831
IE - Irlanda 703
VN - Vietnam 416
BR - Brasile 410
RU - Federazione Russa 397
HK - Hong Kong 390
DE - Germania 388
FI - Finlandia 355
UA - Ucraina 331
IT - Italia 284
FR - Francia 181
GB - Regno Unito 168
SE - Svezia 129
ZA - Sudafrica 95
IN - India 89
CA - Canada 59
BE - Belgio 54
MX - Messico 49
BD - Bangladesh 47
AR - Argentina 45
JP - Giappone 34
TR - Turchia 33
IQ - Iraq 30
PL - Polonia 29
CO - Colombia 27
PK - Pakistan 22
MA - Marocco 20
NL - Olanda 20
EC - Ecuador 18
ES - Italia 18
ID - Indonesia 18
AT - Austria 17
CZ - Repubblica Ceca 13
CL - Cile 12
PH - Filippine 12
IR - Iran 11
MY - Malesia 10
DZ - Algeria 9
SA - Arabia Saudita 9
AL - Albania 8
BO - Bolivia 8
VE - Venezuela 8
EG - Egitto 7
LT - Lituania 7
PY - Paraguay 7
UZ - Uzbekistan 7
AU - Australia 6
RO - Romania 6
AZ - Azerbaigian 5
ET - Etiopia 5
KE - Kenya 5
LB - Libano 5
PE - Perù 5
TN - Tunisia 5
UY - Uruguay 5
GR - Grecia 4
JO - Giordania 4
KG - Kirghizistan 4
NP - Nepal 4
PA - Panama 4
SK - Slovacchia (Repubblica Slovacca) 4
TT - Trinidad e Tobago 4
BH - Bahrain 3
BY - Bielorussia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
EU - Europa 3
GE - Georgia 3
HU - Ungheria 3
IL - Israele 3
KR - Corea 3
NG - Nigeria 3
PS - Palestinian Territory 3
SN - Senegal 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BG - Bulgaria 2
CG - Congo 2
HN - Honduras 2
JM - Giamaica 2
MM - Myanmar 2
PT - Portogallo 2
SI - Slovenia 2
SR - Suriname 2
SV - El Salvador 2
TH - Thailandia 2
TM - Turkmenistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
CH - Svizzera 1
CY - Cipro 1
EE - Estonia 1
GA - Gabon 1
GD - Grenada 1
GY - Guiana 1
HR - Croazia 1
KW - Kuwait 1
Totale 12.922
Salva come PNG Salva come JPEG
Città #
Dublin 702
Chandler 657
Dallas 563
San Jose 512
Singapore 465
Ashburn 420
Beijing 419
Jacksonville 383
Hong Kong 379
Nanjing 323
Ann Arbor 235
Boardman 181
Los Angeles 147
Munich 133
Nanchang 127
Ho Chi Minh City 123
Helsinki 122
Hanoi 111
Princeton 111
Lawrence 109
Shenyang 105
Lauterbourg 102
Wilmington 99
Changsha 97
Medford 95
Johannesburg 88
New York 88
Hebei 81
Shanghai 74
Pavia 70
Moscow 63
Jiaxing 62
Woodbridge 62
Tianjin 60
Hangzhou 58
Turku 57
Orem 56
Brussels 53
Buffalo 51
Milan 49
São Paulo 49
Redondo Beach 44
Council Bluffs 38
Santa Clara 33
Houston 30
Tokyo 28
Frankfurt am Main 27
Verona 27
Chennai 23
San Francisco 23
Washington 23
Montreal 22
Warsaw 22
Chicago 21
Da Nang 21
Seattle 20
Atlanta 19
Brooklyn 19
Denver 19
Dearborn 18
Haiphong 18
Rio de Janeiro 18
Falkenstein 17
London 17
Toronto 17
Auburn Hills 15
Stockholm 15
Baghdad 14
Fairfield 14
Norwalk 14
Nuremberg 14
Poplar 14
The Dalles 14
Ankara 13
Belo Horizonte 13
Dhaka 13
Mexico City 13
Kunming 12
Boston 11
Guangzhou 11
San Giuliano Milanese 11
Buenos Aires 10
Hải Dương 10
Jinan 10
Medellín 10
Mumbai 10
New Delhi 10
Rome 10
Santiago 10
Biên Hòa 9
Des Moines 9
Istanbul 9
Ninh Bình 9
Piscataway 9
Vienna 9
Vigevano 9
Amsterdam 8
Bogotá 8
Brasília 8
Manchester 8
Totale 8.691
Salva come PNG Salva come JPEG
Nome #
A quantitative and qualitative method for direct 2-DE analysis of murine cartilage 179
Kinetic and structural evidences on human prolidase pathological mutants suggest strategies for enzyme functional rescue 179
Combined antiresorptive and new anabolic drug approach in osteogenesis imperfecta zebrafish models 177
Adesion proteins in CHO cells. 170
A de novo G to T transversion in a pro-a1(I) collagen gene for a moderate case of osteogenesis imperfecta. Substitution of cysteine for glycine 178 in the triple helical domain. 167
A Mn(II)-Mn(II) center in human prolidase 164
Improved prolidase activity assay allowed enzyme kinetic characterization and faster prolidase deficiency diagnosis 157
Allele-specific Col1a1 silencing reduces mutant collagen in fibroblasts from Brtl mouse, a model for classical osteogenesis imperfecta. 157
Cartilage histogenesis in a murine model of chondrodysplasia 156
A novel splicing mutation causes an undescribed type of analbuminemia. 154
Molecular characterisation of six patients with prolidase deficiency: identification of the first small duplication in the prolidase gene and of a mutation generating symptomatic and asymptomatic outcomes within the same family. 153
Matrix disruptions, growth, and degradation of cartilage with impaired sulfation. 147
Comparative analysis of the expression of methionine sulfoxide reductase enzymes in human blood cells 145
Insights from a transgenic mouse model on the role of SLC26A2 in health and disease. 145
Diastrophic Dysplasia Sulfate Transporter (SLC26A2) Is Expressed in the Adrenal Cortex and Regulates Aldosterone Secretion. 144
Differential response to intracellular stress in the skin from osteogenesis imperfecta Brtl mice with lethal and non lethal phenotype: a proteomic approach 142
Stability and networks of hydrogen bonds of the collagen triple helical structure: influence of pH and chaotropic nature of three anions. 139
Methionine sulfoxide reductase enzymes (Msr): a comparative analysis of the levels of expression in human blood cells 139
In vivo contribution of amino acid sulfur to cartilage proteoglycan sulfation. 139
Altered signaling in the G1 phase deregulates chondrocyte growth in a mouse model with proteoglycan undersulfation. 139
Partial rescue of biochemical parameters after hematopoietic stem cell transplantation in a patient with prolidase deficiency due to two novel PEPD mutations 137
Differential expression of both extracellular and intracellular proteins is involved in the lethal or nonlethal phenotypic variation of BrtlIV, a murine model for osteogenesis imperfecta 136
Alteration of proteoglycan sulfation affects bone growth and remodeling. 133
4-PBA ameliorates cellular homeostasis in fibroblasts from osteogenesis imperfecta patients by enhancing autophagy and stimulating protein secretion 133
Altered cytoskeletal organization characterized lethal but not surviving Brtl+/- mice: insight on phenotypic variability in osteogenesis imperfecta 133
Cellular stress due to impairment of collagen prolyl hydroxylation complex is rescued by the chaperone 4-phenylbutyrate 133
Beta2-microglobulin isoforms display an heterogeneous affinity for type I collagen. 131
Human recombinant prolidase from eukaryotic and prokaryotic sources. Expression, purification, characterization and long-term stability studies. 130
Characterization of a new PEPD allele causing prolidase deficiency in two unrelated patients: natural-occurrent mutations as a tool to investigate structure-function relationship. 130
Interaction of decorin with CNBr peptides from collagens I and II. Evidence for multiple binding sites and essential lysyl residues in collagen 130
Calcium activated nucleotidase 1 (CANT1) is critical for glycosaminoglycan biosynthesis in cartilage and endochondral ossification 130
Heparin strongly enhances the formation of beta 2-microglobulin amyloid fibrils in the presence of type I collagen 129
Impaired osteoblastogenesis in a murine model of dominant osteogenesis imperfecta: a new target for osteogenesis imperfecta pharmacological therapy 129
Deposition of mutant type I collagen in the extracellular matrix of cultured dermal fibroblasts in osteogenesis imperfecta. 127
The chaperone activity of 4PBA ameliorates the skeletal phenotype of Chihuahua, a zebrafish model for dominant osteogenesis imperfecta 127
Role of the advanced glycation end products receptor in Crohn’s disease inflammation 126
A diastrophic dysplasia sulfate transporter (SLC26A2) mutant mouse: morphological and biochemical characterization of the resulting chondrodysplasia phenotype 124
Neutrophil granulocytes uniquely express, among human blood cells, high levels of Methionine-sulfoxide-reductase enzymes. 123
N-acetylcysteine treatment ameliorates the skeletal phenotype of a mouse model of diastrophic dysplasia 122
Ultrastructural aspects of cartilage histogenesis in a model of chondrodysplasia 122
A novel mutation in the sulphate transporter gene SLC26A2 (DTDST) specific to the Finnish population causes de la Chapelle dysplasia. 121
Analbuminemia in a Swiss family is caused by a C --> T transition at nucleotide 4446 of the albumin gene. 121
Lack of prolidase causes a bone phenotype both in human and in mouse 121
Human prolidase and prolidase deficiency: an overview on the characterization of the enzyme involved in proline recycling and on the effects of its mutations 120
Fast screening of glycosaminoglycan disaccharides by fluorophore-assisted carbohydrate electrophoresis (FACE): applications to biologic samples and pharmaceutical formulations 120
Use of capillary zone electrophoresis for analysis of imidodipeptides in urine of prolidase-deficient patients. 118
Early Fracture Healing is Delayed in the Col1a2 +/G610C Osteogenesis Imperfecta Murine Model 118
Optimization of a capillary electrophoretic method to detect and quantify the Gly-Pro dipeptide in complex matrices from long term cultured prolidase deficiency fibroblasts 117
Anomalous cysteine in type I collagen. Localisation by chemical cleavage of the protein using 2-nitro-5-thiocyanobenzoic acid and by mismatch analysis of cDNA heteroduplexes. 116
N-benzyloxycarbonyl-L-proline: an in vitro inhibitor of prolidase. 116
Zebrafish Collagen Type I: Molecular and Biochemical Characterization of the Major Structural Protein in Bone and Skin 116
Crtap and p3h1 knock out zebrafish support defective collagen chaperoning as the cause of their osteogenesis imperfecta phenotype 116
Polyethylene Glycol-Poly-Lactide-co-Glycolide Block Copolymer-Based Nanoparticles as a Potential Tool for Off-Label Use of N-Acetylcysteine in the Treatment of Diastrophic Dysplasia 115
Self-aggregation of fibrillar collagens I and II involves lysine side chains. 115
Effect of the triterpenoid fraction of Centella asiatica on macromolecules of the connective matrix in human skin fibroblast cultures. 111
Phenotypic variability and abnormal type I collagen unstable at body temperature in a family with mild dominant osteogenesis imperfecta. 111
A chondrodysplasia family produced by mutations in the diastrophic dysplasia sulfate transporter gene: genotype/phenotype correlations 110
In utero transplantation of adult bone marrow decreases perinatal lethality and rescues the bone phenotype in the knock-in murine model for classical, dominant osteogenesis imperfecta 110
Extracellular matrix deposition in cultured dermal fibroblasts from four probands affected by osteogenesis imperfecta. 109
Impaired proteoglycan glycosylation, elevated TGF-β signaling, and abnormal osteoblast differentiation as the basis for bone fragility in a mouse model for gerodermia osteodysplastica 109
Bone cell differentiation and mineralization in wild-type and osteogenesis imperfecta zebrafish are compromised by per- and poly-fluoroalkyl substances (PFAS) 108
Novel nonsense mutation causes analbuminemia in a Moroccan family. 108
Stability of type I collagen peptide trimers. 106
A family of chondrodysplasias caused by mutations in the diastrophic dysplasia sulfate transporter gene and associated with impaired sulfation of proteoglycans. 106
A nucleotide insertion and frameshift cause albumin Kenitra, an extended and O-glycosylated mutant of human serum albumin with two additional disulfide bridges. 106
Knocking out TMEM38B in human foetal osteoblasts hFOB 1.19 by CRISPR/Cas9: A model for recessive OI type XIV 106
Further delineation of CANT1 phenotypic spectrum and demonstration of its role in proteoglycan synthesis. 104
Defective proteoglycan sulfation of the growth plate zones causes reduced chondrocyte proliferation via an altered Indian hedgehog signalling 104
Chondroitin Sulfate N-acetylgalactosaminyltransferase-1 (CSGalNAcT-1) Deficiency Results in a Mild Skeletal Dysplasia and Joint Laxity 102
Bone and connective tissue disorders caused by defects in glycosaminoglycan biosynthesis: a panoramic view 100
Collagen plays an active role in the aggregation of beta 2-microglobulin under physio-pathological conditions of dialysis-related amyloidosis. 99
Mucosal expression of the receptor for the advanced glycation end products (RAGE) in patients with inflammatory bowel disease (IBD) 99
Molecular diagnosis of analbuminemia: A novel mutation identified in two amerindian and two Turkish families 98
Achondrogenesis type 1B is caused by mutations in the diastrophic dysplasia sulfate transporter gene 96
Type I procollagen in the severe non-lethal form of osteogenesis imperfecta. Defective pro-alpha 1(I) chains in a patient with abnormal proteoglycan metabolism and mineral deposits in the dermis. 96
EXT 1 gene mutation induces chondrocyte cytoskeletal abnormalities and collagen expression in the exostoses. 96
Type I collagen CNBr peptides: species and behavior in solution 92
Localization of a structural defect in type I procollagen in a patient affected with the severe non-lethal form of Osteogenesis imperfecta. 92
Improvement of the skeletal phenotype in a mouse model of diastrophic dysplasia after postnatal treatment with N-acetylcysteine 92
Analysis of proteoglycan synthesis and secretion in cell culture systems 91
Skeletal Dysplasias Caused by Sulfation Defects 91
Osteogenesis imperfecta and type I collagen mutations. A lethal variant caused by a Gly910->Ala substitution in the a1(I) chain. 89
Possible role of overglycosylation in the type I collagen triple helical domain in the molecular pathogenesis of osteogenesis imperfecta. 89
Targeting cellular stress in vitro improves osteoblast homeostasis, matrix collagen content and mineralization in two murine models of osteogenesis imperfecta 88
Enzyme replacement therapy in mice lacking arylsulfatase B targets bone-remodeling cells, but not chondrocytes 87
The receptor for the advanced glycation end products is overexpressed in the intestinal mucosa of patients with crohn’s disease 86
The administration of exogenous HSP47 as a collagen-specific therapeutic approach 85
Diastrophic dysplasia sulfate transporter (DTDST) gene is not involved in pseudodiastrophic dysplasia 85
Undersulfation of proteoglycans synthesized by chondrocytes from a patient with achondrogenesis type 1B homozygous for a Leu483Pro substitution in the diastrophic dysplasia sulfate transporter 85
Phenotypic characterization of immortalized chondrocytes from a desbuquois dysplasia type 1 mouse model: A tool for studying defects in glycosaminoglycan biosynthesis 85
FACE analysis as a fast and reliable methodology to monitor the sulfation and total amount of chondroitin sulfate in biological samples of clinical importance. 84
Osteoblasts mineralization and collagen matrix are conserved upon specific Col1a2 silencing 84
FGF signalling regulates bone growth through autophagy 82
In vitro proteoglycan sulfation derived from sulfhydryl compounds in sulfate transporter chondrodysplasias 82
Testing the Cre-mediated genetic switch for the generation of conditional knock-in mice 81
CaMKII inhibition due to TRIC-B loss-of-function dysregulates SMAD signaling in osteogenesis imperfecta 80
Identification of potential non-invasive biomarkers in diastrophic dysplasia 78
Genetic variants of human serum albumin in Italy: point mutants and a carboxyl-terminal variant. 78
Congenital joint dislocations caused by carbohydrate sulfotransferase 3 deficiency in recessive Larsen syndrome and humero-spinal dysostosis. 77
Phenotypic features of carbohydrate sulfotransferase 3 (CHST3) deficiency in 24 patients: congenital dislocations and vertebral changes as principal diagnostic features 77
Totale 11.661
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.579
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.579
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022528 12 10 14 13 13 9 13 40 21 18 87 278
2022/20231.871 180 175 15 151 194 165 6 88 804 20 46 27
2023/2024664 90 141 25 48 63 155 15 40 9 24 28 26
2024/20252.095 54 133 61 61 84 92 88 99 542 62 297 522
2025/20264.849 363 536 560 492 529 225 867 265 435 371 121 85
2026/202740 40 0 0 0 0 0 0 0 0 0 0 0
Totale 13.147